SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer

[1]  Hua Li,et al.  Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells. , 2019, JCI insight.

[2]  K. Nishio,et al.  An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC , 2018, Oncogene.

[3]  D. Delia,et al.  TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage , 2018, Cell Death & Differentiation.

[4]  Jianwei Zhou,et al.  KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance , 2018, International journal of biological sciences.

[5]  Yan Jiao,et al.  Sinomenine Induces G1-Phase Cell Cycle Arrest and Apoptosis in Malignant Glioma Cells Via Downregulation of Sirtuin 1 and Induction of p53 Acetylation , 2018, Technology in cancer research & treatment.

[6]  H. Inuzuka,et al.  SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation , 2018, Protein & Cell.

[7]  R. Reiter,et al.  Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways , 2017, Journal of pineal research.

[8]  Hongchuan Jin,et al.  Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia , 2017, Theranostics.

[9]  C. Zappa,et al.  Non-small cell lung cancer: current treatment and future advances. , 2016, Translational lung cancer research.

[10]  P. Potts,et al.  An Acetyldegron Triggers CRBN to Take Down the "Q". , 2016, Molecular cell.

[11]  Justin M. Reitsma,et al.  Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon. , 2016, Molecular cell.

[12]  Yingying Zhou,et al.  Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC) , 2015, Medical Oncology.

[13]  T. Shiozawa,et al.  Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target , 2015, Laboratory Investigation.

[14]  Shukui Wang,et al.  JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells , 2014, Cell Death and Disease.

[15]  S. Laín,et al.  SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth , 2014, Cell Death and Disease.

[16]  Raj Kumar,et al.  Novel downstream molecular targets of SIRT1 in melanoma: A quantitative proteomics approach , 2014, Oncotarget.

[17]  G. Wood,et al.  SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis , 2014, Cell cycle.

[18]  J. Stow,et al.  Single‐step protease cleavage elution for identification of protein–protein interactions from GST pull‐down and mass spectrometry , 2014, Proteomics.

[19]  S. Nakajima,et al.  Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose) , 2013, Journal of Cell Science.

[20]  Junchao Cai,et al.  miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. , 2013, Cancer research.

[21]  M. Pagano,et al.  mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR. , 2011, Molecular cell.

[22]  Byoung Kil Lee,et al.  Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. , 2011, Human pathology.

[23]  Cuk-Seong Kim,et al.  SIRT1 deacetylates APE1 and regulates cellular base excision repair , 2009, Nucleic acids research.

[24]  Gang Li,et al.  JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks , 2009, Nucleic acids research.

[25]  B. Jung-Hynes,et al.  Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer , 2009, Journal of Biological Chemistry.

[26]  M. Salto‐Tellez,et al.  Function of the SIRT1 protein deacetylase in cancer. , 2007, Biotechnology journal.

[27]  Manel Esteller,et al.  Epigenetics and aging: the targets and the marks. , 2007, Trends in genetics : TIG.

[28]  William Arbuthnot Sir Lane,et al.  SIRT1 regulates the function of the Nijmegen breakage syndrome protein. , 2007, Molecular cell.

[29]  W. Gu,et al.  Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage , 2006, Nature Cell Biology.

[30]  Brian K. Kennedy,et al.  Sirtuins in Aging and Age-Related Disease , 2006, Cell.

[31]  Hidde Ploegh,et al.  Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. , 2004, Molecular cell.

[32]  Delin Chen,et al.  Mammalian SIRT1 Represses Forkhead Transcription Factors , 2004, Cell.

[33]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[34]  R. Frye,et al.  Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. , 1999, Biochemical and biophysical research communications.